Variable | Prison, % (n/N) | Hospital, % (n/N) | p-value | Total% (n/N) |
---|---|---|---|---|
Sex | ||||
Male | 90.48(19/21) | 51.14(45/88) | 0.001 | 58.72(64/109) |
Age | ||||
> 45 years | 14.29(3/21) | 7.95(7/88) | 0.366 | 9.17(10/109) |
Previous TB treatment | ||||
No | 80.95(17/21) | 100.00(88/88) | NA | |
Regions | ||||
Oromia | 33.33(7/21) | 10.23(9/88) | 14.68(16/109) | |
SNNPRS | 66.67(14/21) | 39.77(35/88) | 44.95(49/109) | |
Dire Dawa | – | 11.36(10/88) | 0.001 | 9.17(10/109) |
Harar | – | 15.91(14/88) | 12.84(14/109) | |
Somali | – | 22.70(20/88) | 18.35(20/109) | |
Lineage | ||||
Delhi/CAS | 14.29(3/21) | 17.05(15/88) | 16.51(18/109) | |
Ethiopia_H37Rv like | 42.86(9/21) | 23.86(21/88) | 27.52(30/109) | |
Euro-American Superlineage | 14.29(3/21) | 15.91(14/88) | 15.60(17/109) | |
LAM | 4.76(1/21) | 3.41(3/88) | 3.67(4/109) | |
Ethiopia_3 | 19.05(4/21) | 15.91(14/88) | 16.51(18/109) | |
Haarlem | – | 9.09(8/88) | 0.784 | 7.34(8/109) |
Ural | 4.76(1/21) | 5.68(5/88) | 5.50(6/109) | |
Lineage 7 | – | 3.41(3/88) | 2.75(3/109) | |
EAI | – | 2.27(2/88) | 1.83(2/109) | |
X-type | – | 2.27(2/88) | 1.83(2/109) | |
Beijing | – | 1.14(1/88) | 0.92(1/109) | |
Clustering | ||||
Yes | 28.57(6/21) | 31.82(28/88) | 0.773 | 31.19(34/109) |
Drug resistance | ||||
Streptomycina | 20.00(4/20)c | 14.94(13/87) | 0.577 | 15.89(17/107) |
Isoniazide | 9.52(2/21)b | 6.82(6/88) | 0.669 | 7.34(8/109) |
Rifampicin | 9.52(2/21)b | 4.55(4/88) | 0.369 | 5.50(6/109) |
Ethambutola | 10.00(2/20)b | 3.41(3/88) | 0.205 | 4.63(5/108) |
MDR-resistance | 9.52(2/21)b | 2.27(2/88) | 0.112 | 3.67(4/109) |
Any drug resistance | 19.05(4/21)c | 21.59(19/88) | 0.797 | 21.10(23/109) |